Combined etoposide (VP 16) and cytarabine (ARA-C) for acute myelogenous leukemia (AML) evolving from myelodysplastic syndromes (MDS) or secondary to treatment for malignant disease

Authors
Publication date
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio Istituzionale della Ricerca - Università degli Studi di Pavia

    redirect
    oaioai:iris.unipv.it:11571/444474
    Last time updated on 03/09/2019